Ferroptosis in cancer cells triggers PGE 2 production for tumour immune escape
Ferroptotic cancer cells activate a molecular program that causes increased levels of PGE2, which in turn impairs type 1 conventional dendritic cell function, compromising antitumour CD8+ T cell immunity.